Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 91

Similar articles for PubMed (Select 21643500)

1.

Dyslipidemia associated with chronic kidney disease.

Tsimihodimos V, Mitrogianni Z, Elisaf M.

Open Cardiovasc Med J. 2011;5:41-8. doi: 10.2174/1874192401105010041. Epub 2011 Feb 24.

2.

Dyslipidemia in chronic kidney disease: an approach to pathogenesis and treatment.

Tsimihodimos V, Dounousi E, Siamopoulos KC.

Am J Nephrol. 2008;28(6):958-73. doi: 10.1159/000144024. Epub 2008 Jul 9. Review.

3.

[Dyslipidemia and stroke in patients with chronic kidney disease].

Kes P, Bašić-Kes V, Furic-Cunko V, Mesar I, Bašić-Jukić N.

Acta Med Croatica. 2014 Apr;68(2):141-9. Review. Croatian.

PMID:
26012152
4.

Statins for treatment of dyslipidemia in chronic kidney disease.

Shurraw S, Tonelli M.

Perit Dial Int. 2006 Sep-Oct;26(5):523-39. Review.

5.

Effects of lipid-lowering therapy on reduction of cardiovascular events in patients with end-stage renal disease requiring hemodialysis.

Marrs JC, Saseen JJ.

Pharmacotherapy. 2010 Aug;30(8):823-9. doi: 10.1592/phco.30.8.823. Review.

PMID:
20653359
6.

Lipid abnormalities in kidney disease and management strategies.

Pandya V, Rao A, Chaudhary K.

World J Nephrol. 2015 Feb 6;4(1):83-91. doi: 10.5527/wjn.v4.i1.83. Review.

7.

The utility of non-HDL in managing dyslipidemia of stage 5 chronic kidney disease.

Pennell P, Leclercq B, Delahunty MI, Walters BA.

Clin Nephrol. 2006 Nov;66(5):336-47.

PMID:
17140163
8.
9.

Managing dyslipidemia in chronic kidney disease.

Harper CR, Jacobson TA.

J Am Coll Cardiol. 2008 Jun 24;51(25):2375-84. doi: 10.1016/j.jacc.2008.03.025. Review.

10.

Dyslipidemia in chronic kidney disease: managing a high-risk combination.

Chauhan V, Vaid M.

Postgrad Med. 2009 Nov;121(6):54-61. doi: 10.3810/pgm.2009.11.2077. Review.

PMID:
19940417
11.

Dyslipidemia in Dialysis Patients.

Qunibi WY.

Semin Dial. 2015 Jul;28(4):345-53. doi: 10.1111/sdi.12375. Epub 2015 Apr 9.

PMID:
25855389
12.

Lipotoxicity and impaired high density lipoprotein-mediated reverse cholesterol transport in chronic kidney disease.

Vaziri ND.

J Ren Nutr. 2010 Sep;20(5 Suppl):S35-43. doi: 10.1053/j.jrn.2010.05.010. Review.

PMID:
20797569
13.

Statins and lipid-lowering strategies in cardiorenal patients.

Bianchi S, Grimaldi D, Bigazzi R.

Contrib Nephrol. 2011;171:143-50. doi: 10.1159/000327139. Epub 2011 May 23. Review.

PMID:
21625103
14.

Cardiovascular disease in patients with chronic kidney disease.

Jaradat MI, Molitoris BA.

Semin Nephrol. 2002 Nov;22(6):459-73. Review.

PMID:
12430090
15.

2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.

Tsubakihara Y, Nishi S, Akiba T, Hirakata H, Iseki K, Kubota M, Kuriyama S, Komatsu Y, Suzuki M, Nakai S, Hattori M, Babazono T, Hiramatsu M, Yamamoto H, Bessho M, Akizawa T.

Ther Apher Dial. 2010 Jun;14(3):240-75. doi: 10.1111/j.1744-9987.2010.00836.x.

PMID:
20609178
16.

Chronic inflammation in peritoneal dialysis: the search for the holy grail?

Pecoits-Filho R, Stenvinkel P, Wang AY, Heimbürger O, Lindholm B.

Perit Dial Int. 2004 Jul-Aug;24(4):327-39. Review.

17.

Plasma lipoprotein abnormalities in hemodialysis patients--clinical implications and therapeutic guidelines.

Shoji T, Nishizawa Y.

Ther Apher Dial. 2006 Aug;10(4):305-15. Review.

PMID:
16911182
18.

Cardiovascular disease in patients with chronic kidney disease. A clinical review.

Kaisar M, Isbel N, Johnson DW.

Minerva Urol Nefrol. 2007 Sep;59(3):281-97. Review.

PMID:
17912225
19.

[Lipoprotein disorders in chronic kidney failure, nephrotic syndrome and dialysis].

Kes P, Reiner Z, Brunetta B.

Lijec Vjesn. 2002 Nov-Dec;124(11-12):372-7. Review. Croatian.

PMID:
12679979
20.

[Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].

Cases Amenós A, Goicoechea Diezhandiño M, de Alvaro Moreno F.

Nefrologia. 2008;28 Suppl 3:39-48. Spanish.

PMID:
19018737
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk